Anafranil is a medication with the active ingredient called clomipramine. It is also known by its generic name, clomipramine hydrochloride, and the brand name Clomicalm. Anafranil is used to treat obsessive-compulsive disorder (OCD) by helping to reduce unwanted thoughts and repetitive behaviors.
Anafranil has a price point ranging from £0.26 to £2.1 per pills. Variations in price are linked to the pack’s dimension and the active ingredient dosage (30 or 360 mg).
Anafranil
Clomipramine Hydrochloride
Anafranil is prescribed for the treatment of obsessive-compulsive disorder (OCD). It is also used in treating panic disorder, major depressive disorder, and chronic pain.
The initial adult dose for OCD is typically 25 mg per day, which may be increased gradually. The maintenance dose usually ranges between 100 mg to 250 mg per day, taken in divided doses.
In elderly patients or those with renal or hepatic impairment, the dosage may require adjustment. Regular monitoring and dose titration are advised.
Clomipramine works by inhibiting the reuptake of serotonin and norepinephrine, thereby increasing their levels in the brain and helping to stabilize mood and reduce anxiety.
Side effects include dry mouth, constipation, weight gain, dizziness, and blurred vision. These are generally mild to moderate in intensity.
Serious side effects include arrhythmias, seizures, and severe hypotension. These require immediate medical attention.
Anafranil interacts with monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs), and anticoagulants. Caution is advised when co-prescribing these medications.
Concurrent use of alcohol and Anafranil may exacerbate drowsiness and dizziness. Patients are generally advised to limit or avoid alcohol.
Contraindications include recent myocardial infarction, acute-phase recovery from coronary artery disease, and known hypersensitivity to clomipramine or any component of its formulation.
Clomipramine should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. It is excreted in breast milk, and caution is advised when administering to breastfeeding mothers.
In case of overdose, immediate medical attention is required. Symptoms of overdose include cardiac dysrhythmias, severe hypotension, and convulsions.
Anafranil should be stored at room temperature, away from moisture and direct sunlight. Keep it out of reach of children.
Regular monitoring of blood pressure, heart rate, and plasma levels is recommended. Periodic assessments of liver and kidney function are also advised.
Patients should be advised not to abruptly discontinue Anafranil due to the potential for withdrawal symptoms such as nausea, headache, and malaise.
Clomipramine is well-absorbed following oral administration, with peak plasma levels achieved within 2-8 hours. It has a half-life of approximately 32 hours.
Clomipramine is metabolized in the liver via demethylation and hydroxylation. The primary metabolite, desmethylclomipramine, is also active.
Anafranil is primarily excreted via the kidneys, with approximately 50% of a dose excreted in the urine and 24% via feces as unchanged drug or metabolites.
Patients should be informed about the onset of therapeutic effects, which may take 2 to 3 weeks. They should also be advised to adhere to the prescribed dosage regimen and to report any unusual side effects.
Elderly patients may be more susceptible to the side effects of Anafranil, particularly anticholinergic and cardiovascular effects. Dose adjustments and close monitoring are essential.
Effectiveness of the medication should be assessed periodically through patient self-reports and clinical evaluations to ensure optimal therapeutic outcomes.
Gradual dose reduction is recommended to minimize withdrawal symptoms such as gastrointestinal disturbances, anxiety, and sleep disturbances. A tailored tapering schedule should be followed.
Combination with cognitive-behavioral therapy (CBT) may enhance the overall efficacy of Anafranil in treating obsessive-compulsive disorder.
Generic versions of clomipramine hydrochloride are available, which may offer cost-effective alternatives to the brand name Anafranil.
Regular follow-ups and patient education by healthcare providers are imperative to manage side effects, ensure compliance, and adjust dosages as required.